This announcement is a separate document:
シンバイオ製薬：EUにおけるブリンシドフォビルのオーファンドラッグ指定取得のお知らせ
SymBio Pharmaceuticals: Notice of acquisition of brincidofovir orphan drug designation in the EU
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.